Genome BC collaborates with Chile and Norway to sequence salmon genome
The economically important, environmentally sensitive Atlantic salmon species will have its genome fully sequenced, thanks to an international collaboration involving researchers, funding agencies and industry from Canada, Chile and Norway. Genome BC is partnering with the Chilean Economic Development Agency, InnovaChile, Norwegian Research Council, Norwegian Fishery and Aquaculture Industry Research Fund to form the International Cooperation to Sequence the Atlantic Salmon Genome.
The Cooperation will invest approximately US$6 million in phase one of a multi-phased project to produce a genome sequence that identifies and maps all of the genes in the Atlantic salmon genome and can act as a reference/guide sequence for the genomes of other salmonids (e.g. Pacific salmon, rainbow trout and more distantly related fish such as smelt and pike.)
With salmonid product exports from Norway, Chile and Canada valued at US$3.4 billion, US$2.3 billion and US$0.6 billion, respectively in 2007, the sequenced genome will be an important public resource that may lead to better management of wild fish stocks, breeding selection for commercially important traits, and elements of food quality, security and traceability.
In addition, the fully annotated salmon genome will provide important clues about the impact of cultured fish escapees on wild populations, conservation of populations at risk, strategies for combating pathogens, as well as allowing for more accurate assessments of the sustainability of aquatic environments.
Dr. Ben Koop sits on the Cooperation's Executive Science Committee. "This project is an international effort to address - in a whole new way - questions that are of economic and social importance to aquaculture, conservation, and the environment," he says.
"The genomic data that we will acquire will be crucial to the development of new methods and products that will assist the world's wild fisheries and aquaculture industries," says Genome BC's Chief Scientific Officer, Dr. Pierre Meulien. "In addition, this research builds on knowledge obtained through earlier fisheries research funded by Genome BC."
Most read news
Other news from the department science

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
YM Biosciences Reports Additional Results From Nimotuzumab Phase III Study in Children With Glioma
Dementia

Making the oxygen we breathe, a photosynthesis mechanism exposed
Ashley_Treatment
List_of_homologues_of_the_human_reproductive_system
Squamous_cell_carcinoma
Mitral_stenosis
Disease_theory_of_alcoholism
Multiple_endocrine_neoplasia
Cardiac_amyloidosis
